According to filings with the U.S. Securities and Exchange Commission, PredxBio is raising $4,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Dusty Majumdar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About PredxBio
The convergence of unbiased spatial analytics and explainable AI ushers in a new era of precision pathology. The novel insights from our platforms reveal the existence of intermediate cell types and their functional states as well as communications between cells. Our solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. We believe the convergence of unbiased spatial analytics and explainable AI ushers in a new era of spatially intelligent biology. The novel insights from our platforms reveal the existence of intermediate cell types and their functional states as well as communications between them. We offer software as a service (SaaS) applications as well as knowledge -based contracted services, harnessing proprietary explainable AI and unbiased spatial analytics. Our solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. 

To learn more about PredxBio, visit http://www.predxbio.com

Contact:
Dusty Majumdar, Chief Executive Officer
412-212-3115

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.